...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Nature clinical practice:Urology >Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra.
【24h】

Aggressive combined-modality therapy for squamous cell carcinoma of the female urethra.

机译：侵袭性联合疗法治疗女性尿道鳞状细胞癌。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: A 48-year old woman presented to an emergency department with acute urinary retention necessitating suprapubic catheterization. INVESTIGATIONS: Pelvic examination under anesthetic by both a urologist and gynecologist, biopsy of the urethral tumor and of the cervix, pathological analysis, MRI of the pelvis, CT of the chest, abdomen and pelvis. DIAGNOSIS: Poorly differentiated squamous cell carcinoma of the urethra, T4N0M0. MANAGEMENT: The patient received two cycles of neoadjuvant TIP (paclitaxel, ifosfamide, cisplatin) chemotherapy, resulting in complete remission, followed by consolidative chemoradiation therapy (radiation therapy given with synchronous weekly cisplatin). She remained relapse-free 48 months after diagnosis, with normal voiding and sexual function.
机译：背景：一名48岁的妇女因急诊尿retention留而被急诊就诊，需要耻骨上导尿。调查：泌尿科医师和妇科医师在麻醉下进行骨盆检查，对尿道肿瘤和宫颈进行活检，病理分析，骨盆MRI，胸部CT，腹部和骨盆CT。诊断：尿道低分化鳞状细胞癌，T4N0M0。处理：该患者接受了两个周期的新辅助TIP（紫杉醇，异环磷酰胺，顺铂）化疗，从而完全缓解，随后进行了巩固放化疗（每周同步同步进行放疗）。诊断后48个月，她保持无复发，排尿和性功能正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号